Numeric Investors’s MacroGenics MGNX Stock Holding History

Numeric Investors’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-76,465	Closed	-$1.56M	–	1099
2016 Q4	$1.56M	Buy	76,465 +17,600	+30%	+$443K	0.01%	552
2016 Q3	$1.76M	Buy	58,865 +10,000	+20%	+$297K	0.02%	494
2016 Q2	$1.32M	Sell	48,865 -501,863	-91%	-$11.3M	0.01%	523
2016 Q1	$10.3M	Buy	550,728 +188,397	+52%	+$3.59M	0.11%	194
2015 Q4	$11.2M	Buy	362,331 +133,756	+59%	+$4.06M	0.12%	182
2015 Q3	$4.9M	Buy	+228,575	New	+$7.17M	0.06%	244

Other funds holding MGNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BRC

Blue Ridge Capital New York $215M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Numeric Investors's MGNX Position: Q1 2017 in Review

Numeric Investors sold out of MacroGenics (MGNX) in Q1 2017, closing a stake of 76,465 shares — an estimated $1.56M sold.

Numeric Investors first reported a position in MGNX in Q3 2015 and held it in 6 quarters. The position peaked at $11.2M in Q4 2015. 111 funds tracked by Wall St. Rank hold MGNX as of Q1 2017.

Numeric Investors reported no remaining MacroGenics position as of Q1 2017 after selling out during the quarter.
Numeric Investors sold 76,465 MacroGenics shares in Q1 2017, an estimated $1.56M.
Numeric Investors first reported a position in MacroGenics in Q3 2015 and held it in 6 quarters.
Numeric Investors's MacroGenics position peaked at $11.2M in Q4 2015.
111 funds tracked by Wall St. Rank held MacroGenics as of Q1 2017.

Based on Numeric Investors's 13F filing for Q1 2017, filed 15 May 2017.